Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

The stimulation of mineralocorticoid receptors is linked to the development of hypertension and cardiovascular or renal damage in patients with diabetes, and the blockade of these receptors may be an effective treatment option. This open-label study with a 12-week treatment period assessed the antih...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, Hiroshi, Ito, Sadayoshi, Rakugi, Hiromi, Okuda, Yasuyuki, Nishioka, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075891/
https://www.ncbi.nlm.nih.gov/pubmed/31239535
http://dx.doi.org/10.1038/s41440-019-0270-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075891/
https://www.ncbi.nlm.nih.gov/pubmed/31239535
http://dx.doi.org/10.1038/s41440-019-0270-2

Ejemplares similares